Hanlon Suzanne M. Insider Profile

4 Followers
Hanlon Suzanne M., Sec, VP & General Counsel at Zynerba Pharmaceuticals, holds 80.69K shares in Zynerba Pharmaceuticals (Ticker: ZYNE).
Hanlon Suzanne M.

Hanlon Suzanne M.
Zynerba Pharmaceuticals (ZYNE)
Sec, VP & General Counsel

Not Ranked
Hanlon Suzanne M. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34K
100.00%
A breakdown of Hanlon Suzanne M.'s holdings

Insider Roles

Zynerba Pharmaceuticals
(ZYNE)
Sec, VP & General Counsel
Roles that Hanlon Suzanne M. holds in companies

Most Profitable Insider Trade

Stock:
Zynerba Pharmaceuticals
(ZYNE)
Rating:Informative Buy
Date:Aug 07, 2018 - Aug 07, 2019
Return:+89.20%
The most profitable trade made by Hanlon Suzanne M.

Hanlon Suzanne M.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Zynerba Pharmaceuticals
Jan 25, 2021
Sec, VP & General Counsel
Uninformative Buy
$33.97K
Success Rate for ZYNE
1 out of 1 profitable transactions on ZYNE
100%
Average Return for ZYNE
Average return per transaction on ZYNE
+89.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 25, 2021
Uninformative Buy
$0.00
-
$0.00
Aug 07, 2018
Informative Buy
$22.04K
-
$5.80
+89.20%
List of latest transactions for each holding click on a transaction to see Hanlon Suzanne M.'s performance on stock

Hanlon Suzanne M. insider profile FAQ

What is the percentage of profitable transactions made by Hanlon Suzanne M.?
The percentage of profitable transactions made by Hanlon Suzanne M. is ―.
    What is the average return per transaction made by Hanlon Suzanne M.?
    The average return per transaction made by Hanlon Suzanne M. is ―.
      What stocks does Hanlon Suzanne M. hold?
      Hanlon Suzanne M. holds: ZYNE stocks.
        What was Hanlon Suzanne M.’s latest transaction?
        Hanlon Suzanne M. latest transaction was an Uninformative Buy of ―.
          What was Hanlon Suzanne M.'s most profitable transaction?
          Hanlon Suzanne M.’s most profitable transaction was an Informative Buy of ZYNE stock on August 7, 2018. The return on the trade was 89.20%.
            What is Hanlon Suzanne M.'s role in Zynerba Pharmaceuticals?
            Hanlon Suzanne M.'s role in Zynerba Pharmaceuticals is Sec, VP & General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.